MEASURE: Molecular Evaluation of AML Patients After Stem Cell Transplant to Understand Relapse Events

Primary Objective

The study is a non-interventional, observational study for the purpose of prospective determination of the clinical utility of measurable residual disease (MRD) testing for relapse and survival of patients with AML undergoing alloHCT.

Is this Study for You?

Let's Get Started!

Details
Age

Adult

Locations

CTRC Inpatient
University of Colorado Hospital

Principal Investigator
Photograph of Marc Schwartz

Marc Schwartz

Study ID

Protocol Number: 23-0054

More information available at ClinicalTrials.gov: NCT05224661

Categories

Is this Study for You?

Let's Get Started!

Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers